Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Bioasis Technologies Inc
(OP:
BIOAF
)
0.0001
UNCHANGED
Last Price
Updated: 9:30 AM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0001
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0001
Today's Range
0.0001 - 0.0001
52wk Range
0.0001 - 0.0130
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bioasis Provides Corporate Update and Announces Suspension of Operations
June 20, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Provides Update on Business Operations
March 23, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Performance
YTD
-97.92%
-97.92%
1 Month
N/A
N/A
3 Month
-96.67%
-96.67%
6 Month
-98.00%
-98.00%
1 Year
-98.33%
-98.33%
More News
Read More
Bioasis Announces AGM Results and Provides Update on Financial Position
February 03, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc
January 23, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022
January 19, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
January 11, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
December 19, 2022
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Technologies Inc. Announces Shareholder Webinar
December 14, 2022
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
December 13, 2022
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022
October 28, 2022
From
Bioasis Technologies Inc.
Via
GlobeNewswire
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
May 11, 2022
Via
Benzinga
Bioasis Technologies’ xB3 Platform Unlocks Revolutionary Neurological Disease Treatments
February 18, 2022
Via
Get News
Bioasis Technologies Breaks through Blood-Brain Barrier with xB3 platform, Revolutionizing Neurological Disease Treatment
October 22, 2021
Via
Get News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.